Featured Research

from universities, journals, and other organizations

Predicting The Outcome Of Drug-induced Liver Disease

Date:
July 19, 2005
Source:
John Wiley & Sons, Inc.
Summary:
A study published in the August 2005 issue of Hepatology analyzed reports of suspected drug-induced liver injury received by the Swedish Adverse Drug Reactions Advisory Committee (SADRAC) in order to evaluate the validity of Hy's rule and determine what factors might predict the outcome of different forms of DILD.

Drug-induced liver disease (DILD), a potential complication seen with some medications, is usually not life-threatening, but may occasionally be more severe with a high mortality, requiring a liver transplant in selected cases. During the last decade, drug-induced liver injury has led to the withdrawal of a number of drugs from the market. Hy's rule, an observation by the late Dr. Hyman Zimmerman, states that the combination of high liver cell damage as measured by liver enzymes and jaundice induced by a drug is associated with a fatality rate of 10-50 percent. This rule has been advocated by the FDA for assessing the liver toxicity of newly developed drugs, but it has never been scientifically validated.

A study by Einar Bjφrnsson, M.D., Ph.D. and Rolf Olsson, M.D., Ph.D. of the department of internal medicine at Sahlgrenska University Hospital in Gothenburg, Sweden and published in the August 2005 issue of Hepatology, analyzed reports of suspected drug-induced liver injury received by the Swedish Adverse Drug Reactions Advisory Committee (SADRAC) in order to evaluate the validity of Hy's rule and determine what factors might predict the outcome of different forms of DILD.

Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD), published by John Wiley & Sons, Inc. is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/hepatology.

A total of 784 reports were included in the analysis, each with bilirubin greater than twice upper normal limits and ALT (a liver enzyme that when elevated indicates liver damage) greater than three times upper normal limits. Of these, 409 cases had hepatocellular or HC liver injury (damage to liver cells); while 206 had cholestatic (bile flow) injury and 169 had mixed liver injury. In 633 cases, one drug was suspected of causing the liver injury, while in 151 cases more than one drug may have been responsible. A total of 72 patients died from liver failure or underwent liver transplants. Patients with HC liver injury had a higher mortality than the other two forms of DILD. Those who died or had transplants were older than those who recovered and had higher bilirubin and AST (a liver enzyme also used as an indicator of liver damage) and ALT levels. In the cholestatic/mixed group, bilirubin and AST/ALT ratios were significantly higher in those who died or underwent transplants.

An analysis showed that AST and bilirubin were found to independently predict death or transplant in the general study population and within the HC group (as well as age in the HC group), while within the cholestatic and mixed injury groups, bilirubin was an independent predictor. "Our analysis is unique because it is performed in a large cohort of patients with severe DILD, giving the opportunity to elucidate the most important factors for outcome," the authors state. They note that adverse drug reactions are significantly underreported, which is a limitation of the present study. The study supports Hy's rule in that HC injury had a mortality rate of approximately 10 percent, but the rule seemed to be highly variable depending on the drug associated with the damage.

"We conclude that in accordance with Hy's rule, the HC jaundice has a high but variable mortality rate, depending on the drug involved," the authors state. "AST and bilirubin levels are the most important predictors of death or liver transplantation."

###

Article: "Outcome and Prognostic Markers in Severe Drug-Induced Liver Disease," Einar Bjφrnsson, Rolf Olsson, Hepatology; August 2005; Published Online: July 15, 2005. Article is available via Wiley InterScience at http://www.interscience.wiley.com/journal/hepatology.


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "Predicting The Outcome Of Drug-induced Liver Disease." ScienceDaily. ScienceDaily, 19 July 2005. <www.sciencedaily.com/releases/2005/07/050719002825.htm>.
John Wiley & Sons, Inc.. (2005, July 19). Predicting The Outcome Of Drug-induced Liver Disease. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/2005/07/050719002825.htm
John Wiley & Sons, Inc.. "Predicting The Outcome Of Drug-induced Liver Disease." ScienceDaily. www.sciencedaily.com/releases/2005/07/050719002825.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Costs Keep Mounting

Ebola Costs Keep Mounting

Reuters - Business Video Online (Sep. 23, 2014) — The WHO has warned up to 20,000 people could be infected with Ebola over the next few weeks. As Sonia Legg reports, the implications for the West African countries suffering from the disease are huge. Video provided by Reuters
Powered by NewsLook.com
Ebola Cases Could Reach 1.4 Million Within 4 Months

Ebola Cases Could Reach 1.4 Million Within 4 Months

Newsy (Sep. 23, 2014) — Health officials warn that without further intervention, the number of Ebola cases in Liberia and Sierra Leone could reach 1.4 million by January. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Cases to Triple in Weeks Without Drastic Action

WHO: Ebola Cases to Triple in Weeks Without Drastic Action

AFP (Sep. 23, 2014) — The number of Ebola infections will triple to 20,000 by November, soaring by thousands every week if efforts to stop the outbreak are not stepped up radically, the WHO warned in a study on Tuesday. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
5 Ways Men Can Prevent Most Heart Attacks

5 Ways Men Can Prevent Most Heart Attacks

Newsy (Sep. 23, 2014) — No surprise here: A recent study says men can reduce their risk of heart attack by maintaining a healthy lifestyle, which includes daily exercise. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins